Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$8.57
-0.30-3.38%
At close: -
$8.75
0.182.10%
After Hours: Dec 20, 6:28 PM EDT
Comments
Loading...
Cormedix (NASDAQ:CRMD) Stock, Analyst Ratings, Price Targets, Forecasts
Cormedix Inc has a consensus price target of $15.83 based on the ratings of 6 analysts. The high is $19 issued by JMP Securities on April 9, 2024. The low is $12 issued by RBC Capital on December 19, 2024. The 3 most-recent analyst ratings were released by RBC Capital, Needham, and Truist Securities on December 19, 2024, October 31, 2024, and October 22, 2024, respectively. With an average price target of $15.67 between RBC Capital, Needham, and Truist Securities, there's an implied 79.05% upside for Cormedix Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
Needham
Truist Securities
Rodman & Renshaw
JMP Securities
1calculated from analyst ratings
Analyst Ratings for Cormedix
Data brought to you by Benzinga APIs
FAQ
What is the target price for Cormedix (CRMD) stock?
The latest price target for Cormedix (NASDAQ:CRMD) was reported by RBC Capital on December 19, 2024. The analyst firm set a price target for $12.00 expecting CRMD to rise to within 12 months (a possible 37.14% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cormedix (CRMD)?
The latest analyst rating for Cormedix (NASDAQ:CRMD) was provided by RBC Capital, and Cormedix maintained their outperform rating.
When was the last upgrade for Cormedix (CRMD)?
There is no last upgrade for Cormedix
When was the last downgrade for Cormedix (CRMD)?
There is no last downgrade for Cormedix.
When is the next analyst rating going to be posted or updated for Cormedix (CRMD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cormedix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cormedix was filed on December 19, 2024 so you should expect the next rating to be made available sometime around December 19, 2025.
Is the Analyst Rating Cormedix (CRMD) correct?
While ratings are subjective and will change, the latest Cormedix (CRMD) rating was a maintained with a price target of $11.00 to $12.00. The current price Cormedix (CRMD) is trading at is $8.75, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.